Intrinsic value of Teladoc - TDOC

Previous Close

$68.55

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$68.55

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of TDOC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  59.74
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  123
  434
  670
  1,002
  1,454
  2,051
  2,819
  3,785
  4,969
  6,394
  8,077
  10,029
  12,262
  14,780
  17,585
  20,677
  24,052
  27,706
  31,632
  35,825
  40,278
  44,985
  49,942
  55,144
  60,589
  66,277
  72,208
  78,384
  84,810
  91,492
  98,437
Variable operating expenses, $m
 
  356
  513
  735
  1,037
  1,436
  1,950
  2,595
  3,386
  4,338
  5,463
  6,702
  8,193
  9,876
  11,750
  13,816
  16,071
  18,513
  21,137
  23,938
  26,914
  30,059
  33,371
  36,847
  40,485
  44,286
  48,249
  52,376
  56,670
  61,134
  65,775
Fixed operating expenses, $m
 
  26
  26
  27
  27
  28
  28
  29
  30
  30
  31
  32
  32
  33
  34
  35
  35
  36
  37
  38
  39
  39
  40
  41
  42
  43
  44
  45
  46
  47
  48
Total operating expenses, $m
  194
  382
  539
  762
  1,064
  1,464
  1,978
  2,624
  3,416
  4,368
  5,494
  6,734
  8,225
  9,909
  11,784
  13,851
  16,106
  18,549
  21,174
  23,976
  26,953
  30,098
  33,411
  36,888
  40,527
  44,329
  48,293
  52,421
  56,716
  61,181
  65,823
Operating income, $m
  -71
  53
  130
  240
  389
  587
  841
  1,161
  1,553
  2,025
  2,583
  3,296
  4,036
  4,871
  5,801
  6,826
  7,945
  9,157
  10,459
  11,849
  13,326
  14,887
  16,531
  18,256
  20,062
  21,948
  23,915
  25,963
  28,094
  30,310
  32,614
EBITDA, $m
  -63
  189
  306
  470
  693
  988
  1,368
  1,846
  2,432
  3,137
  3,970
  4,937
  6,042
  7,289
  8,678
  10,209
  11,880
  13,689
  15,634
  17,710
  19,915
  22,246
  24,701
  27,277
  29,974
  32,791
  35,728
  38,787
  41,969
  45,278
  48,718
Interest expense (income), $m
  2
  29
  51
  83
  129
  190
  272
  376
  508
  669
  864
  1,093
  1,359
  1,664
  2,007
  2,389
  2,811
  3,271
  3,769
  4,305
  4,876
  5,483
  6,125
  6,801
  7,510
  8,252
  9,028
  9,836
  10,678
  11,554
  12,465
Earnings before tax, $m
  -74
  24
  79
  157
  261
  397
  570
  784
  1,045
  1,356
  1,719
  2,203
  2,677
  3,207
  3,794
  4,437
  5,134
  5,886
  6,690
  7,545
  8,450
  9,404
  10,406
  11,455
  12,552
  13,696
  14,887
  16,127
  17,416
  18,756
  20,148
Tax expense, $m
  0
  6
  21
  42
  70
  107
  154
  212
  282
  366
  464
  595
  723
  866
  1,024
  1,198
  1,386
  1,589
  1,806
  2,037
  2,281
  2,539
  2,810
  3,093
  3,389
  3,698
  4,020
  4,354
  4,702
  5,064
  5,440
Net income, $m
  -74
  17
  58
  114
  190
  290
  416
  573
  763
  990
  1,255
  1,608
  1,954
  2,341
  2,770
  3,239
  3,748
  4,297
  4,883
  5,508
  6,168
  6,865
  7,596
  8,362
  9,163
  9,998
  10,868
  11,773
  12,714
  13,692
  14,708

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  66
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  304
  1,188
  1,835
  2,745
  3,983
  5,619
  7,725
  10,369
  13,615
  17,519
  22,128
  27,478
  33,594
  40,492
  48,178
  56,648
  65,896
  75,906
  86,664
  98,151
  110,351
  123,248
  136,827
  151,079
  165,998
  181,580
  197,829
  214,751
  232,356
  250,662
  269,689
Adjusted assets (=assets-cash), $m
  238
  1,188
  1,835
  2,745
  3,983
  5,619
  7,725
  10,369
  13,615
  17,519
  22,128
  27,478
  33,594
  40,492
  48,178
  56,648
  65,896
  75,906
  86,664
  98,151
  110,351
  123,248
  136,827
  151,079
  165,998
  181,580
  197,829
  214,751
  232,356
  250,662
  269,689
Revenue / Adjusted assets
  0.517
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
  0.365
Average production assets, $m
  27
  709
  1,096
  1,639
  2,378
  3,355
  4,613
  6,192
  8,130
  10,461
  13,213
  16,408
  20,060
  24,179
  28,769
  33,827
  39,349
  45,327
  51,750
  58,610
  65,895
  73,596
  81,705
  90,216
  99,124
  108,429
  118,132
  128,236
  138,749
  149,681
  161,042
Working capital, $m
  62
  -6
  -9
  -14
  -20
  -29
  -39
  -53
  -70
  -90
  -113
  -140
  -172
  -207
  -246
  -289
  -337
  -388
  -443
  -502
  -564
  -630
  -699
  -772
  -848
  -928
  -1,011
  -1,097
  -1,187
  -1,281
  -1,378
Total debt, $m
  44
  367
  599
  925
  1,368
  1,954
  2,707
  3,654
  4,816
  6,214
  7,864
  9,779
  11,969
  14,438
  17,190
  20,222
  23,533
  27,116
  30,968
  35,080
  39,448
  44,065
  48,926
  54,028
  59,369
  64,948
  70,765
  76,823
  83,126
  89,679
  96,491
Total liabilities, $m
  73
  425
  657
  983
  1,426
  2,012
  2,765
  3,712
  4,874
  6,272
  7,922
  9,837
  12,027
  14,496
  17,248
  20,280
  23,591
  27,174
  31,026
  35,138
  39,506
  44,123
  48,984
  54,086
  59,427
  65,006
  70,823
  76,881
  83,184
  89,737
  96,549
Total equity, $m
  231
  763
  1,178
  1,762
  2,557
  3,607
  4,959
  6,657
  8,741
  11,247
  14,206
  17,641
  21,567
  25,996
  30,930
  36,368
  42,305
  48,732
  55,638
  63,013
  70,846
  79,125
  87,843
  96,993
  106,571
  116,575
  127,006
  137,870
  149,173
  160,925
  173,140
Total liabilities and equity, $m
  304
  1,188
  1,835
  2,745
  3,983
  5,619
  7,724
  10,369
  13,615
  17,519
  22,128
  27,478
  33,594
  40,492
  48,178
  56,648
  65,896
  75,906
  86,664
  98,151
  110,352
  123,248
  136,827
  151,079
  165,998
  181,581
  197,829
  214,751
  232,357
  250,662
  269,689
Debt-to-equity ratio
  0.190
  0.480
  0.510
  0.520
  0.530
  0.540
  0.550
  0.550
  0.550
  0.550
  0.550
  0.550
  0.550
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
  0.560
Adjusted equity ratio
  0.693
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642
  0.642

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -74
  17
  58
  114
  190
  290
  416
  573
  763
  990
  1,255
  1,608
  1,954
  2,341
  2,770
  3,239
  3,748
  4,297
  4,883
  5,508
  6,168
  6,865
  7,596
  8,362
  9,163
  9,998
  10,868
  11,773
  12,714
  13,692
  14,708
Depreciation, amort., depletion, $m
  8
  137
  175
  230
  304
  401
  527
  685
  879
  1,112
  1,387
  1,641
  2,006
  2,418
  2,877
  3,383
  3,935
  4,533
  5,175
  5,861
  6,590
  7,360
  8,171
  9,022
  9,912
  10,843
  11,813
  12,824
  13,875
  14,968
  16,104
Funds from operations, $m
  -56
  154
  233
  344
  494
  691
  943
  1,258
  1,642
  2,102
  2,642
  3,249
  3,960
  4,759
  5,646
  6,621
  7,683
  8,829
  10,058
  11,369
  12,758
  14,224
  15,767
  17,384
  19,075
  20,841
  22,681
  24,596
  26,589
  28,660
  30,812
Change in working capital, $m
  -4
  -2
  -3
  -5
  -6
  -8
  -11
  -14
  -17
  -20
  -24
  -27
  -31
  -35
  -39
  -43
  -47
  -51
  -55
  -59
  -62
  -66
  -69
  -73
  -76
  -80
  -83
  -86
  -90
  -94
  -97
Cash from operations, $m
  -52
  156
  237
  349
  500
  699
  954
  1,271
  1,659
  2,122
  2,666
  3,276
  3,991
  4,794
  5,686
  6,665
  7,730
  8,880
  10,113
  11,427
  12,820
  14,290
  15,836
  17,457
  19,151
  20,920
  22,764
  24,683
  26,679
  28,753
  30,910
Maintenance CAPEX, $m
  0
  -44
  -71
  -110
  -164
  -238
  -336
  -461
  -619
  -813
  -1,046
  -1,321
  -1,641
  -2,006
  -2,418
  -2,877
  -3,383
  -3,935
  -4,533
  -5,175
  -5,861
  -6,590
  -7,360
  -8,171
  -9,022
  -9,912
  -10,843
  -11,813
  -12,824
  -13,875
  -14,968
New CAPEX, $m
  -3
  -265
  -387
  -543
  -739
  -977
  -1,257
  -1,579
  -1,938
  -2,331
  -2,752
  -3,195
  -3,652
  -4,119
  -4,589
  -5,058
  -5,522
  -5,978
  -6,424
  -6,860
  -7,285
  -7,701
  -8,109
  -8,511
  -8,908
  -9,305
  -9,703
  -10,105
  -10,513
  -10,931
  -11,362
Cash from investing activities, $m
  26
  -309
  -458
  -653
  -903
  -1,215
  -1,593
  -2,040
  -2,557
  -3,144
  -3,798
  -4,516
  -5,293
  -6,125
  -7,007
  -7,935
  -8,905
  -9,913
  -10,957
  -12,035
  -13,146
  -14,291
  -15,469
  -16,682
  -17,930
  -19,217
  -20,546
  -21,918
  -23,337
  -24,806
  -26,330
Free cash flow, $m
  -26
  -154
  -221
  -304
  -403
  -516
  -639
  -769
  -899
  -1,023
  -1,133
  -1,240
  -1,302
  -1,331
  -1,322
  -1,270
  -1,174
  -1,032
  -843
  -607
  -326
  0
  368
  775
  1,221
  1,703
  2,218
  2,765
  3,342
  3,947
  4,580
Issuance/(repayment) of debt, $m
  18
  160
  232
  326
  443
  586
  754
  947
  1,162
  1,398
  1,650
  1,915
  2,190
  2,470
  2,751
  3,033
  3,311
  3,584
  3,851
  4,113
  4,368
  4,617
  4,861
  5,102
  5,341
  5,579
  5,817
  6,058
  6,303
  6,554
  6,812
Issuance/(repurchase) of shares, $m
  3
  268
  358
  469
  604
  761
  936
  1,125
  1,321
  1,517
  1,704
  1,826
  1,973
  2,087
  2,165
  2,199
  2,189
  2,130
  2,023
  1,867
  1,664
  1,415
  1,122
  788
  415
  6
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  21
  428
  590
  795
  1,047
  1,347
  1,690
  2,072
  2,483
  2,915
  3,354
  3,741
  4,163
  4,557
  4,916
  5,232
  5,500
  5,714
  5,874
  5,980
  6,032
  6,032
  5,983
  5,890
  5,756
  5,585
  5,817
  6,058
  6,303
  6,554
  6,812
Total cash flow (excl. dividends), $m
  -5
  275
  369
  491
  645
  831
  1,051
  1,302
  1,584
  1,892
  2,221
  2,502
  2,861
  3,226
  3,594
  3,962
  4,325
  4,682
  5,031
  5,373
  5,706
  6,031
  6,351
  6,666
  6,977
  7,288
  8,035
  8,823
  9,645
  10,501
  11,392
Retained Cash Flow (-), $m
  -52
  -286
  -416
  -584
  -795
  -1,050
  -1,352
  -1,697
  -2,084
  -2,506
  -2,959
  -3,435
  -3,927
  -4,429
  -4,934
  -5,438
  -5,937
  -6,427
  -6,906
  -7,375
  -7,832
  -8,280
  -8,718
  -9,150
  -9,578
  -10,004
  -10,432
  -10,864
  -11,303
  -11,752
  -12,215
Prev. year cash balance distribution, $m
 
  82
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  31
  49
  76
  113
  164
  232
  319
  428
  562
  723
  913
  1,133
  1,386
  1,670
  1,987
  2,336
  2,718
  3,131
  3,574
  4,048
  4,551
  5,083
  5,643
  6,231
  6,847
  7,489
  8,159
  8,857
  9,584
  10,339
Cash available for distribution, $m
 
  71
  -47
  -93
  -150
  -219
  -301
  -395
  -500
  -615
  -738
  -933
  -1,066
  -1,202
  -1,340
  -1,477
  -1,612
  -1,745
  -1,875
  -2,002
  -2,127
  -2,248
  -2,367
  -2,484
  -2,601
  -2,716
  -2,396
  -2,041
  -1,658
  -1,252
  -824
Discount rate, %
 
  6.30
  6.62
  6.95
  7.29
  7.66
  8.04
  8.44
  8.86
  9.31
  9.77
  10.26
  10.78
  11.31
  11.88
  12.47
  13.10
  13.75
  14.44
  15.16
  15.92
  16.72
  17.55
  18.43
  19.35
  20.32
  21.33
  22.40
  23.52
  24.70
  25.93
PV of cash for distribution, $m
 
  67
  -41
  -76
  -113
  -152
  -189
  -224
  -253
  -276
  -290
  -318
  -312
  -298
  -278
  -253
  -225
  -195
  -165
  -137
  -111
  -88
  -67
  -51
  -37
  -27
  -16
  -9
  -4
  -2
  -1
Current shareholders' claim on cash, %
  100
  92.3
  86.3
  81.5
  77.5
  74.3
  71.5
  69.2
  67.2
  65.5
  64.1
  62.9
  61.9
  61.0
  60.2
  59.6
  59.1
  58.6
  58.3
  58.0
  57.8
  57.6
  57.5
  57.4
  57.4
  57.4
  57.4
  57.4
  57.4
  57.4
  57.4

Teladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company's solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. As of July 17, 2017, it served over 7,500 employers, health plans, health systems and other entities. As of July 17, 2017, these clients collectively purchased access to its solution for more than 20 million Members. As of December 31, 2016, it had over 30 health plans as Clients. Its solutions consist of an integrated technology platform, Provider network, consumer engagement strategies and entrenched distribution channels.

FINANCIAL RATIOS  of  Teladoc (TDOC)

Valuation Ratios
P/E Ratio -42.8
Price to Sales 25.7
Price to Book 13.7
Price to Tangible Book
Price to Cash Flow -60.9
Price to Free Cash Flow -57.6
Growth Rates
Sales Growth Rate 59.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -62.5%
Cap. Spend. - 3 Yr. Gr. Rate 24.6%
Financial Strength
Quick Ratio 33
Current Ratio 0
LT Debt to Equity 18.2%
Total Debt to Equity 19%
Interest Coverage -36
Management Effectiveness
Return On Assets -27%
Ret/ On Assets - 3 Yr. Avg. -29.5%
Return On Total Capital -30.8%
Ret/ On T. Cap. - 3 Yr. Avg. -35%
Return On Equity -36.1%
Return On Equity - 3 Yr. Avg. -44.4%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 74%
Gross Margin - 3 Yr. Avg. 74.7%
EBITDA Margin -52%
EBITDA Margin - 3 Yr. Avg. -50%
Operating Margin -57.7%
Oper. Margin - 3 Yr. Avg. -54.8%
Pre-Tax Margin -60.2%
Pre-Tax Margin - 3 Yr. Avg. -58%
Net Profit Margin -60.2%
Net Profit Margin - 3 Yr. Avg. -58%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

TDOC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the TDOC stock intrinsic value calculation we used $271 million for the last fiscal year's total revenue generated by Teladoc. The default revenue input number comes from 2016 income statement of Teladoc. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our TDOC stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 6.3%, whose default value for TDOC is calculated based on our internal credit rating of Teladoc, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Teladoc.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of TDOC stock the variable cost ratio is equal to 91.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $25 million in the base year in the intrinsic value calculation for TDOC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 13.9% for Teladoc.

Corporate tax rate of 27% is the nominal tax rate for Teladoc. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the TDOC stock is equal to 11.3%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for TDOC are equal to 163.6%.

Life of production assets of 10 years is the average useful life of capital assets used in Teladoc operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for TDOC is equal to -1.4%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $559 million for Teladoc - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 55 million for Teladoc is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Teladoc at the current share price and the inputted number of shares is $3.8 billion.

RELATED COMPANIES Price Int.Val. Rating
EVHC Envision Healt 44.30 13.61  str.sell

COMPANY NEWS

▶ Teladoc Is the Future of Healthcare   [Jul-16-18 01:06PM  InvestorPlace]
▶ Teladoc to Announce Second Quarter 2018 Financial Results   [Jul-11-18 08:35AM  GlobeNewswire]
▶ Why Teladoc Inc. Stock Is Up 87% So Far This Year   [Jul-09-18 03:10PM  Motley Fool]
▶ About to Buy Bitcoin? Look at These 3 Companies First   [Jul-03-18 11:06AM  Motley Fool]
▶ Is Teladoc Incs (NYSE:TDOC) Liquidity Good Enough?   [Jun-22-18 09:22AM  Simply Wall St.]
▶ The 6 Stocks on the MFM Team's Radar This Week   [Jun-19-18 07:20AM  Motley Fool]
▶ Medical Software Rallies As Health Care's Tech Conversion Accelerates   [Jun-08-18 12:06PM  Investor's Business Daily]
▶ Why Teladoc Inc. Stock Gained 18% in May   [Jun-07-18 03:12PM  Motley Fool]
▶ Whats the Right Price to Buy Teladoc Inc?   [May-30-18 12:01PM  InvestorPlace]
▶ The 3 Stocks on the MFM Team's Radar This Week   [May-25-18 02:38PM  Motley Fool]
▶ 3 Stocks Your Children Will Brag About Someday   [May-14-18 10:59AM  Motley Fool]
▶ 3 Healthcare Stocks Growing Over 100%   [08:16AM  Motley Fool]
▶ How to Gauge Under Armour's Progress   [07:51PM  Motley Fool]
▶ 3 Stocks Making Big Moves After Earnings   [03:31PM  Motley Fool]
▶ Teladoc Announces First Quarter 2018 Results   [May-01-18 04:01PM  GlobeNewswire]
▶ Teladoc to Announce First Quarter 2018 Financial Results   [Apr-18-18 08:35AM  GlobeNewswire]
▶ 3 Growth Stocks for In-the-Know Investors   [Apr-06-18 06:20AM  Motley Fool]
▶ The Analysts Are Right About Teladoc Inc Its a Buy!   [Mar-29-18 10:15AM  InvestorPlace]
▶ KeyBanc: 6 Reasons To Buy Teladoc   [Mar-15-18 10:04AM  Benzinga]
▶ Teladoc to Participate in Upcoming Investor Conferences   [Mar-09-18 08:21AM  GlobeNewswire]
▶ Harry Boxers four tech stocks to watch   [Mar-07-18 11:39AM  MarketWatch]
▶ Teladoc Announces Expanded Collaboration with Microsoft   [Mar-01-18 04:25PM  GlobeNewswire]
▶ 5 of the Most Disruptive Stocks in Healthcare   [Feb-28-18 09:15AM  Motley Fool]
▶ Teladoc Announces Full Year and Fourth Quarter 2017 Results   [Feb-27-18 04:01PM  GlobeNewswire]
▶ Teladoc Inc to Host Earnings Call   [12:00PM  ACCESSWIRE]
▶ This Health Care Stock Hits Buy Zone On Flu, Medicare Law   [Feb-22-18 04:18PM  Investor's Business Daily]
▶ 2 Stocks I Bought Last Week, 1 Stock I Sold   [Feb-14-18 01:44PM  Motley Fool]
▶ 3 Megacompanies Want to Shake Up Healthcare   [Feb-06-18 09:50PM  Motley Fool]
▶ Healthcare: Is Celgene Going to Buy Juno Therapeutics?   [Jan-18-18 05:24PM  Motley Fool]
▶ Why Teladoc Inc. Stock Fell Monday   [Jan-08-18 04:27PM  Motley Fool]
▶ Keep Your Eye on Twitter This Year   [Dec-29-17 08:19PM  Motley Fool]
▶ ETFs with exposure to Teladoc, Inc. : December 28, 2017   [Dec-28-17 12:42PM  Capital Cube]
▶ Teladoc to Participate in Upcoming Investor Conference   [Dec-19-17 08:35AM  GlobeNewswire]
▶ Teladoc Scores Relative Strength Rating Upgrade   [Dec-08-17 03:00AM  Investor's Business Daily]
Financial statements of TDOC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.